Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.

Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37403700
Remyelination Therapy in Multiple SclerosisLaquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease.Laquinimod in the treatment of relapsing remitting multiple sclerosis.Human neural precursor cells promote neurologic recovery in a viral model of multiple sclerosis.Laquinimod reduces neuroaxonal injury through inhibiting microglial activation.Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosisRestoration of axon conduction and motor deficits by therapeutic treatment with glatiramer acetate.Immune parameters of patients treated with laquinimod, a novel oral therapy for the treatment of multiple sclerosis: results from a double-blind placebo-controlled study.Laquinimod arrests experimental autoimmune encephalomyelitis by activating the aryl hydrocarbon receptorRemyelination in multiple sclerosis: what do we know and where are we going?Synaptopathy connects inflammation and neurodegeneration in multiple sclerosis.Role of Oligodendrocyte Dysfunction in Demyelination, Remyelination and Neurodegeneration in Multiple Sclerosis.Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMSLaquinimod ameliorates excitotoxic damage by regulating glutamate re-uptake.Consistent induction of chronic experimental autoimmune encephalomyelitis in C57BL/6 mice for the longitudinal study of pathology and repair.Increase in chemokine CXCL1 by ERβ ligand treatment is a key mediator in promoting axon myelination.Laquinimod protects the optic nerve and retina in an experimental autoimmune encephalomyelitis model.
P2860

Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis.

Item
http://www.wikidata.org/entity/Q37403700
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 September 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Therapeutic laquinimod treatme ...... e model of multiple sclerosis.
@en
Therapeutic laquinimod treatme ...... e model of multiple sclerosis.
@nl
type
label
Therapeutic laquinimod treatme ...... e model of multiple sclerosis.
@en
Therapeutic laquinimod treatme ...... e model of multiple sclerosis.
@nl
prefLabel
Therapeutic laquinimod treatme ...... e model of multiple sclerosis.
@en
Therapeutic laquinimod treatme ...... e model of multiple sclerosis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Therapeutic laquinimod treatme ...... e model of multiple sclerosis.
@en
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P5875
P698
P921
P932